Evidence map›Paper›PMID 33400147›Full record

ReviewAnnals of nuclear medicine2021

An overview of the developments and potential applications of

Philippa L Bresser, Mariza Vorster, Mike M Sathekge

Abstract readReview
PubMed Publisher
In one paragraph

Review in Annals of nuclear medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Journal of medical radiation sciences · 2022
    Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Philippa L BresserDepartment of Radiography, Faculty of Health Sciences, School of Healthcare Sciences, University of Pretoria, HW Snyman Building North, Room 4-33, Bophelo Road, Gezina, Pretoria, 0002, South Africa. pippa.bresser@up.ac.za.ORCID http://orcid.org/0000-0002-9093-2957
Mariza VorsterDepartment of Nuclear Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
Mike M SathekgeDepartment of Nuclear Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-invasive imaging of hypoxia plays a role in monitoring the body's adaptive response or the development of pathology under hypoxic conditions. Various techniques to image hypoxia have been investigated with a shift towards the use of molecular imaging using PET/CT. The role of hypoxia-specific radiopharmaceuticals such as radiolabelled nitroimidazoles is well documented particularly in the oncologic setting. With the increasing utilisation of in-house labelling with a PET benchtop generator, such as the

Indexed as

AnimalsChelating AgentsContrast MediaGallium RadioisotopesHumansHypoxiaIsotope LabelingMacrocyclic CompoundsNitroimidazolesPositron Emission Tomography Computed TomographyRadiopharmaceuticalsChelating AgentsContrast MediaGallium RadioisotopesMacrocyclic CompoundsNitroimidazolesRadiopharmaceuticals68Ga-hypoxia imaging68Ga-nitroimidazole PET/CTNovel applicationsTuberculosis

Identifiers

PMID33400147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.